Press Room

Carnival game mimics eye growth - 3/24/2015
The motion of coins in a “Penny Pusher” carnival game is similar to the movement of cells in the eye’s lens, as described in a new study published in Investigative Ophthalmology & Visual Science (IOVS). This new insight may help scientists understand how the eye maintains its precise shape — critical for clear vision — and how cataracts develop.

Restoring Vision to the Blind - 1/7/2015
Scientists have long known that species such as amphibians and fish can regenerate retinal cells — so why can’t mammals? This and related questions are the premise for the third report from the Albert and Mary Lasker Foundation and the International Retinal Research Foundation’s 10-year collaboration, recently published in the ARVO journal Translational Vision Science & Technology (TVST).

New findings show chronic high blood pressure increases risk of glaucoma - 12/22/2014
A new study published in Investigative Ophthalmology & Visual Science (IOVS) has found that chronic (long term) hypertension increases a person’s susceptibility to glaucoma. These results suggest that doctors should consider a patient’s blood pressure levels in managing the potentially blinding eye disorder.

New poll: Americans fear blindness more than loss of other senses, strongly support more funding for research - 9/18/2014
According to a new poll, Americans across racial and ethnic groups describe losing eyesight as potentially having the greatest impact on their day-to-day life — more so than other conditions, including loss of memory, hearing and speech.

ARVO members honored with world’s largest prize in eye research - 9/10/2014
Seven members of the Association for Research in Vision and Ophthalmology (ARVO) were named today as recipients of the 2014 António Champalimaud Vision Award, the highest distinction in ophthalmology and visual science, for their pioneering work to treat age-related macular degeneration (AMD) and diabetic retinopathy, the most important causes of blindness in high and middle income countries. The prize is worth €1 million (U.S. $1.3 million; greater than the Nobel Prize award).

Is glaucoma a brain disease? - 6/5/2014
Findings from a new study published in Translational Vision Science & Technology (TVST) show the brain, not the eye, controls the cellular process that leads to glaucoma. The results may help develop treatments for one of the world’s leading causes of irreversible blindness, as well as contribute to the development of future therapies for preserving brain function in other age-related disorders like Alzheimer’s.

Mieler begins term as ARVO president - 5/22/2014
William F. Mieler, MD, FARVO (University of Illinois at Chicago), is the new president of the Association for Research in Vision and Ophthalmology (ARVO). He succeeds Justine Smith, FRANZCO, PhD, FARVO (Flinders University), whose one-year term ended this month following the ARVO Annual Meeting.

Emerging trends and hot topics: Presented Thursday, May 8 at the ARVO Annual Meeting - 5/8/2014
In their own words, First Authors at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Thursday, May 8.

New automated tool can screen for diabetic retinopathy - 5/8/2014
Scientists have developed a computer program to screen for diabetic retinopathy, a potentially blinding condition that may affect every person with diabetes. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week.

Emerging trends and hot topics: Presented Wednesday, May 7 at the ARVO Annual Meeting - 5/7/2014
In their own words, First Authors at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Wednesday, May 7. 

Non-invasive technique can identify genetic carriers of eye disease - 5/7/2014
Scientists have developed a non-invasive technique to determine if individuals carry a gene for an inherited eye disease known as retinitis pigmentosa. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. 

Elevating brain fluid pressure could prevent vision loss - 5/7/2014
Scientists have found that pressure from the fluid surrounding the brain plays a role in maintaining proper eye function, opening a new direction for treating glaucoma — the second leading cause of blindness worldwide. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. 

Study shows remote evaluation as effective as a doctor’s visit for AMD patients - 5/7/2014
Researchers have found that patients received similar care for wet age-related macular degeneration (AMD) whether being evaluated by a doctor in-person or remotely. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. 

Researchers find new drug treatment for eye muscle condition - 5/7/2014
In another example of serendipity advancing scientific research, investigators have discovered a new class of drugs to treat an eye condition called nystagmus. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla.

Emerging Trends and hot topics: Presented Tuesday, May 6 at the ARVO Annual Meeting - 5/6/2014
In their own words, First Authors at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Tuesday, May 6.

Patients with AMD may not need monthly injections - 5/6/2014
Researchers have found that, contrary to previous clinical trial findings, monthly injections to counteract age-related macular degeneration (AMD) may not be necessary. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla.

Emerging Trends and hot topics: Presented Monday, May 5 at the ARVO Annual Meeting - 5/5/2014
In their own words, First Authors at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology explain their findings. Their abstracts were designated as some of the newest and most innovative research presented on Monday, May 5.

Simulated model of eye's 3D structure facilitates stem cells transplant - 5/5/2014
Scientists have developed a model that mimics the complex structure of the cornea to enable the transplant of healthy corneal stem cells. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando Fla.

Cataract surgery decreases risk of falls in older patients - 5/5/2014
New research finds that cataract surgery dramatically decreases the number of falls individuals suffer due to poor vision. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla. 

First reversible glue bandage could save injured soldiers' vision - 5/5/2014
Scientists have developed the first reversible glue that could be used on the battlefield to treat eye injuries, potentially saving soldiers’ vision. The research is being presented at the 2014 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Orlando, Fla.

12Next
Advertisement
FASEB 2015